NiKang Therapeutics

An early stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs

News and Events

November 04, 2019 -- NiKang Therapeutics Appoints Y. Peter Li, Ph.D., as Chief Executive Officer and Board Director Read More